G protein-coupled receptor signaling in VTA dopaminergic neurons bidirectionally regulates the acute locomotor response to amphetamine but does not affect behavioral sensitization.
Amphetamine
/ pharmacology
Animals
Behavior, Animal
/ drug effects
Central Nervous System Stimulants
/ pharmacology
Cocaine
/ pharmacology
Designer Drugs
/ pharmacology
Dopamine Plasma Membrane Transport Proteins
/ genetics
Dopaminergic Neurons
/ drug effects
Male
Metabolism
/ drug effects
Mice
Mice, Inbred C57BL
Motor Activity
/ drug effects
Receptors, G-Protein-Coupled
/ drug effects
Ventral Tegmental Area
/ drug effects
Amphetamine
Chemogenetics
Cocaine
DREADDs
Dopamine
Dopamine transporter
G protein-coupled receptor signaling
Hyperlocomotion
Journal
Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217
Informations de publication
Date de publication:
15 12 2019
15 12 2019
Historique:
received:
18
02
2019
revised:
31
05
2019
accepted:
03
06
2019
pubmed:
8
6
2019
medline:
15
7
2020
entrez:
8
6
2019
Statut:
ppublish
Résumé
Amphetamine (AMPH) acts as a substrate of the dopamine transporter (DAT) and causes a dramatic increase in extracellular dopamine (DA). Upon entering DA neurons, AMPH promotes DA efflux via DAT through a mechanism implicating depletion of DA from vesicular stores, activation of kinase pathways and transporter phosphorylation. Despite the role of intracellular signaling for AMPH action, it remains elusive how the response to AMPH is affected in vivo by metabotropic regulation via G protein coupled receptor signaling pathways. Here, we show by employment of Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) that the acute hyperlocomotor response to AMPH is bidirectionally regulated by metabotropic input to VTA DA neurons with a markedly enhanced response upon activation of a Gs-coupled pathway and a markedly decreased locomotor response upon activation of a Gi-coupled pathway. The unique mechanism of action for AMPH was underlined by the absence of an effect of Gs activation on the locomotor response to the DAT inhibitor cocaine. Regardless of the profound effect on the acute AMPH response, repeated Gs activation or Gi activation did not affect development of AMPH sensitization. Furthermore, activation of a Gs-pathway or activation of a Gi-pathway in DA neurons did not have any effect on the AMPH-induced locomotor response in the AMPH sensitized mice. This suggests induction of alterations in DA neuronal functions that overrule the stimulatory or inhibitory effect of metabotropic input seen in drug-naïve mice. The data thereby underline the remarkable strength of maladaptive changes that occur upon intake of strong psychostimulants. This article is part of the issue entitled 'Special Issue on Neurotransmitter Transporters'.
Identifiants
pubmed: 31173760
pii: S0028-3908(19)30209-6
doi: 10.1016/j.neuropharm.2019.06.002
pii:
doi:
Substances chimiques
Central Nervous System Stimulants
0
Designer Drugs
0
Dopamine Plasma Membrane Transport Proteins
0
Receptors, G-Protein-Coupled
0
Slc6a3 protein, mouse
0
Amphetamine
CK833KGX7E
Cocaine
I5Y540LHVR
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
107663Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.